LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
SNOA
Sonoma Pharmaceuticals, Inc.
There isn't enough reported data to score SNOA yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNOA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Weak | |
| Unavailable |
SNOA's revenue is currently strong, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
SNOA PE Valuation
SNOA has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
SNOA Forward outlook
There aren't enough analyst estimates for SNOA to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over SNOA on earnings quality, reporting a profit while its opponent remains loss making.
SNOA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.91 | +$2.30 |
| Q2 2026 | -$1.22 | +$2.26 |
| Q1 2026 | -$1.89 | +$2.23 |
| Q4 2021 | -$54.20 | -$33.60 |
| Q3 2021 | -$54.40 | -$25.80 |
| Q2 2021 | -$52.40 | -$4.40 |
| Q1 2021 | -$39.40 | +$0.40 |
SNOA is still losing money, but far less than before: $0.91 per share over the past year, against $54.40 at its worst in late 2021.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over SNOA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over SNOA on profitability, with a higher operating margin.
SNOA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.2M | +28% |
| Q2 2026 | $6.4M | +60% |
| Q1 2026 | $5.6M | +48% |
| Q4 2025 | $4.3M | +22% |
| Q3 2025 | $5.6M | +57% |
| Q2 2025 | $4M | +18% |
| Q1 2025 | $3.8M | +9.2% |
| Q4 2024 | $3.6M | +14% |
SNOA's revenue has grown year over year for nine quarters in a row: $7M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4% | +10 points |
| Q2 2026 | -0.6% | +27 points |
| Q1 2026 | -6.3% | +11 points |
| Q4 2025 | -16% | +13 points |
| Q3 2025 | -6% | +18 points |
| Q2 2025 | -27% | +7.3 points |
| Q1 2025 | -17% | +24 points |
| Q4 2024 | -29% | -2 points |
SNOA's operating margin was 4% last quarter, up 10 points from the same quarter a year ago, near the top of its range since 2019.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over SNOA on cash generation, producing positive trailing cash flow while its opponent burns cash.
SNOA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$778K | -$133K |
| Q2 2026 | -$651K | +$1.5M |
| Q1 2026 | -$548K | -$406K |
| Q4 2025 | -$811K | -244% |
| Q3 2025 | -$645K | -297% |
| Q2 2025 | -$2.1M | -$1.2M |
| Q1 2025 | -$142K | -192% |
| Q4 2024 | $563K | +$1.7M |
SNOA has burned cash in almost every quarter: −$3M over the past year, against −$2M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over SNOA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
SNOA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +28% | +1.1M shares |
| 1 year | +199% | +3.3M shares |
| 3 years | +4591% | +4.8M shares |
SNOA has 5M diluted shares, up 199% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
SNOA Net Leverage
SNOA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
SNOA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 18.2 | Oversold |
SNOA's weekly RSI is 38 (neutral) and its Stochastic is 18 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
SNOA PE vs Healthcare Sector
SNOA has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over SNOA on trend strength, trading above more of its moving averages.
SNOA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.17 | 0% above |
| 20 week MA | $1.23 | 4.9% below |
| 50 week MA | $1.91 | 39% below |
| 100 week MA | $2.60 | 55% below |
| 200 week MA | $6.66 | 82% below |
SNOA is in a downtrend: it's below all five of its weekly moving averages, and 82% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over SNOA on returns for 2026, with the stronger performance.
SNOA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $88.2 | $163.6 | +85% |
| 2021 | $163.6 | $97.0 | -41% |
| 2022 | $97.0 | $23.0 | -76% |
| 2023 | $23.0 | $3.61 | -84% |
| 2024 | $3.61 | $2.75 | -24% |
| 2025 | $2.75 | $3.61 | +31% |
| 2026 YTD | $3.61 | $1.17 | -68% |
SNOA has finished lower in four of the last six years. It's down 68% so far in 2026.